Gibson Center for Behavioral Change Now Offering GLP-1 Weight Loss Trial with Research Assistant Emily McClendon

The Gibson Center for Behavioral Change is now offering a new GLP-1 weight loss trial designed to help individuals explore innovative treatment options for opiod addiction. Research Assistant Emily McClendon says the program will give qualifying participants access to cutting-edge medications that have shown promising results in helping patients quit the spiral. The trial aims to better understand the long-term effectiveness and benefits of GLP-1 therapies, while also providing support and monitoring throughout the process. McClendon says the center hopes the study will open doors for people struggling to get off prescription drugs.